Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
06/2010
06/17/2010US20100150999 Therapy of cancer based on targeting adaptive, innate and/or regulatory component of the immune response
06/17/2010US20100150969 immune response
06/17/2010US20100150960 Compositions and methods for chitosan enhanced immune response
06/17/2010US20100150953 Ii-KEY/HER-2/NEU HYBRID CANCER VACCINE
06/17/2010US20100150952 pH-RESPONSIVE POLYMER CARRIER COMPOSITIONS FOR CYTOSOLIC PROTEIN DELIVERY
06/17/2010US20100150950 Human antibodies that bind cd70 and uses thereof
06/17/2010US20100150948 Materials and methods for improved immunoglycoproteins
06/17/2010US20100150946 Methods and Compositions for Treating Prostate Cancer or Inducing a Humoral Immune Response Against Prostate Cancer
06/17/2010US20100150940 Anti-igf antibodies
06/17/2010US20100150935 Use of an anti-cxcr4 antibody in the treatment of cancer
06/17/2010US20100150932 Use of vascular endothelial growth factor receptor 1+ cells in treating and monitoring cancer and in screening for chemotherapeutics
06/17/2010US20100150928 Methods and compositions relating to zpa polypeptides
06/17/2010US20100150927 Cell death inducer
06/17/2010US20100150925 Treatment of b-cell cancers with anti-cd70 antibody-drug conjugates
06/17/2010US20100150921 KID31 And Antibodies That Bind Thereto
06/17/2010US20100150919 Crystal structures of neuropilin fragments and neuropilin-antibody complexes
06/17/2010US20100150918 Cross-species-specific binding domain
06/17/2010US20100150910 Use of monoclonal antibodies specific to the o-acetylated form of gd2 ganglioside for treatment of certain cancers
06/17/2010US20100150907 Pro115 antibody compositions and methods of use
06/17/2010US20100150903 Method for Treating Oncological Diseases
06/17/2010US20100150901 26199, 33530, 33949, 47148, 50226, 58764, 62113, 32144, 32235, 23565, 13305, 14911, 86216, 25206, and 8843 molecules and uses therefor
06/17/2010US20100150896 Diaminoquinazoline inhibitors of dihydrofolate reductase
06/17/2010US20100150894 Composition for prevention of cancer
06/17/2010US20100150893 Methods of organ regeneration
06/17/2010US20100150889 Polycistronic Vector For Human Induced Pluripotent Stem Cell Production
06/17/2010US20100150884 Anticancer Agent to Be Combined with Telomelysin
06/17/2010US20100150879 Methods for the detection, isolation, and use of lipid phosphate phosphatase-3-positive stem cells
06/17/2010US20100150872 Polypeptides derived from the hemopexin-like domain of metalloproteinase mmp-2
06/17/2010US20100150869 Use of tellurium compounds for treatment of basal cell carcinoma and/or actinic keratosis
06/17/2010US20100150863 Hydroxy methyl phenyl pyrazolyl urea compound useful in treatment of cancer
06/17/2010US20100150844 Use of 8-quinolinol and its analogs to target cancer stem cells
06/17/2010US20100150836 Radiolabelled benzamide analogues, their synthesis and use in diagnostic imaging
06/17/2010US20100150834 High affinity ephb receptor binding compounds and methods of use thereof
06/17/2010US20100150831 Modulators of cxcr7
06/17/2010US20100150830 Method of treating cancer
06/17/2010US20100150828 Radioactive gold nanoparticles and methods of making and using them
06/17/2010US20100150827 Pyrido [2, 3-d] pyrimidin-7-one compounds as inhibitors of p13k-alpha for the treatment of cancer
06/17/2010CA2747185A1 Compounds for treating cancer
06/17/2010CA2746514A1 Gnaq targeted dsrna compositions and methods for inhibiting expression
06/17/2010CA2746475A1 Antitumor combination combining ave8062 and docetaxel
06/17/2010CA2746422A1 Kinase inhibitor compounds
06/17/2010CA2746339A1 Proliferation-associated modulation of the splicing of the integrin alpha 6 isoforms
06/17/2010CA2746256A1 Methods and compositions for specific modulation of mcl-1
06/17/2010CA2746101A1 Human antibodies against tissue factor
06/17/2010CA2746070A1 Process for the preparation of asymmetrical bis(thiosemicarbazones)
06/17/2010CA2746058A1 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6)1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27)j16,21,23-decaene citrate salt
06/17/2010CA2745970A1 Dihydropyrimidopyrimidine derivative
06/17/2010CA2745959A1 Dihydropyrimidopyrimidine derivatives
06/17/2010CA2745922A1 Pyridyloxyindoles inhibitors of vegf-r2 and use thereof for treatment of disease
06/17/2010CA2745849A1 Novel human endogenous retorviral erv3 variant and uses thereof for diagnosing ovarian cancer
06/17/2010CA2745052A1 Alpha-derivatives of cis-monounsaturated fatty acids for use as medicines
06/17/2010CA2744512A1 Isoform specific anti-her4 antibodies
06/17/2010CA2740341A1 Anti-igf antibodies
06/16/2010EP2196541A1 Anti-glypican-3 antibody having improved kinetics in plasma
06/16/2010EP2196475A1 INTERFERON ALPHA 2a MODIFIED BY POLYETHYLENE GLYCOL, ITS SYNTHESIS PROCESS AND APPLICATION
06/16/2010EP2196472A2 Compositions and methods for generating an immune response utilizing alphavirus-based vector systems
06/16/2010EP2196463A1 Preparation of 5,6-dimethylxanthone-4-acetic acid, the derivatives prepared and pharmaceutical formulations thereof
06/16/2010EP2196460A1 Sulfonic acid salt compound of 4-carbamoyl-5-hydroxy-imidazole derivative
06/16/2010EP2196459A1 5-membered heterocyclic compound
06/16/2010EP2196222A1 Tricarbonyl complexes of rhenium and technetium comprising amino acids as bidentate ligands and their use as radiotherapeutic chemotoxic agents.
06/16/2010EP2196219A1 Destruction of tumor cells expressing low to medium levels of tumor associated target antigens by trifunctional bispecific antibodies
06/16/2010EP2196218A2 Use of anti-TNFalpha antibodies and another drug
06/16/2010EP2196217A1 Packaging of immunostimulatory substances into virus-like particles: method of preparation and use
06/16/2010EP2196216A1 New vaccine composition and use of surfactants as immuno-adjuvant
06/16/2010EP2196213A1 Immunogenic LHRH compositions and methods relating thereto
06/16/2010EP2196212A1 Preparation and method of administering vaccine and iontophoresis device using the preparation
06/16/2010EP2196209A1 Ctl inducer composition
06/16/2010EP2196205A1 Topoisomerase poisons
06/16/2010EP2196204A1 Myrothecium sp. mycelial extract for inhibiting tumor cells growth
06/16/2010EP2195425A1 Pkib and naaladl2 for target genes of prostate cancer therapy and diagnosis
06/16/2010EP2195320A1 Pyrazolo-pyrazines derivatives used as g protein inhibitors
06/16/2010EP2195301A1 Crystalline chemotherapeutic
06/16/2010EP2195300A1 Crystalline chemotherapeutic
06/16/2010EP2195299A1 Crystalline chemotherapeutic
06/16/2010EP2195298A1 Crystalline indazole-derived chemotherepeutic
06/16/2010EP2195297A1 Crystalline chemotherapeutic
06/16/2010EP2195030A1 Isoflavone formulation
06/16/2010EP2195012A2 Use of a peptide as a therapeutic agent
06/16/2010EP2195003A1 Combination therapy for pancreatic cancer using an antigenic peptide and chemotherapeutic agent
06/16/2010EP2029580B1 Novel indol-pyrrol derivatives for the treatment of proliferative and inflammatory diseases
06/16/2010EP1625847B1 Medical use of a tetrahydrotriazolo[4,3-a]pyrazine
06/16/2010EP1492526B1 Conjugated prodrugs of cc-1065 analogs
06/16/2010EP1436281B1 Piperidine- and piperazineacetamides as 17beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
06/16/2010EP1364010B1 Immunomodulatory polynucleotides and methods of using the same
06/16/2010EP1307233B1 Therapeutic polyanhydride compounds for drug delivery
06/16/2010EP1091924B1 Novel retinoids and use thereof
06/16/2010CN1951403B Polyporus rhinoceros cooke extract having anticancer and immunity enhancing activity and preparation method thereof
06/16/2010CN1938307B 9-substituted 8-oxoadenine compound
06/16/2010CN1930162B Tetrahydropyridoindole derivatives
06/16/2010CN1894258B Compositions useful as inhibitors of protein kinases
06/16/2010CN1889969B Application of herbal compositions in preparation of medicine for treating prostate cancer
06/16/2010CN1889949B PDK-1/Akt signaling inhibitors
06/16/2010CN1886141B T-type calcium channel inhibitor
06/16/2010CN1879672B Effective components of glabrous sarcandra herb - total polyphenol, its preparation method and application
06/16/2010CN1871234B 2-amino-4-heteroarylethyl thiazoline derivatives and their use as inhibitors of inducible NO-synthase
06/16/2010CN1867566B Aminopyrones and their use as ATM inhibitors
06/16/2010CN1861101B Application of extractive of Hypericum sampsonii Hance to control RXR alpha acceptor target
06/16/2010CN1857232B Biodegradable nano magnetic capsule loading medicine and its preparing process
06/16/2010CN1812997B Pharmaceutical composition outside stomach intestine containing somatostatin analogue
06/16/2010CN1771032B Polymorphs of pyrrole substituted 2-indolinone protein kinase inhibitors
1 ... 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 ... 2211